These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25024761)

  • 21. The effectiveness of theory- and model-based lifestyle interventions on HbA1c among patients with type 2 diabetes: a systematic review and meta-analysis.
    Doshmangir P; Jahangiry L; Farhangi MA; Doshmangir L; Faraji L
    Public Health; 2018 Feb; 155():133-141. PubMed ID: 29422139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of hemoglobin A1c in predicting diabetes risk.
    Edelman D; Olsen MK; Dudley TK; Harris AC; Oddone EZ
    J Gen Intern Med; 2004 Dec; 19(12):1175-80. PubMed ID: 15610327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
    Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
    JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of electronic health record system functionalities to support the patient recruitment process in clinical trials.
    Schreiweis B; Trinczek B; Köpcke F; Leusch T; Majeed RW; Wenk J; Bergh B; Ohmann C; Röhrig R; Dugas M; Prokosch HU
    Int J Med Inform; 2014 Nov; 83(11):860-8. PubMed ID: 25189709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of HbA1c screening during outreach events for prediabetes subject recruitment for clinical research.
    Paglialunga S; Bond R; Jaycox SH
    Trials; 2018 Jan; 19(1):60. PubMed ID: 29357915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized diabetes management recommendations at hospital discharge based on a computerized, pre-hospitalization clinical profile analysis: A prospective, electronic health records-based study.
    Wasserstrum Y; Peles-Bortz A; Dabahi S; Gringauz I; Tirosh A; Zimlichman E; Segal G
    Int J Health Plann Manage; 2019 Oct; 34(4):e1854-e1861. PubMed ID: 31523844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus.
    Spratt SE; Pereira K; Granger BB; Batch BC; Phelan M; Pencina M; Miranda ML; Boulware E; Lucas JE; Nelson CL; Neely B; Goldstein BA; Barth P; Richesson RL; Riley IL; Corsino L; McPeek Hinz ER; Rusincovitch S; Green J; Barton AB; ; Kelley C; Hyland K; Tang M; Elliott A; Ruel E; Clark A; Mabrey M; Morrissey KL; Rao J; Hong B; Pierre-Louis M; Kelly K; Jelesoff N
    J Am Med Inform Assoc; 2017 Apr; 24(e1):e121-e128. PubMed ID: 27616701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of electronic medical records for clinical research in the management of type 2 diabetes.
    Kamal KM; Chopra I; Elliott JP; Mattei TJ
    Res Social Adm Pharm; 2014; 10(6):877-884. PubMed ID: 24556384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rates of glycaemic deterioration in a real-world population with type 2 diabetes.
    Donnelly LA; Zhou K; Doney ASF; Jennison C; Franks PW; Pearson ER
    Diabetologia; 2018 Mar; 61(3):607-615. PubMed ID: 29260253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affect school and script analysis versus basic body awareness therapy in the treatment of psychological symptoms in patients with diabetes and high HbA1c concentrations: two study protocols for two randomized controlled trials.
    Melin EO; Svensson R; Gustavsson SÅ; Winberg A; Denward-Olah E; Landin-Olsson M; Thulesius HO
    Trials; 2016 Apr; 17(1):221. PubMed ID: 27121185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.
    Kim JH; Ta CN; Liu C; Sung C; Butler AM; Stewart LA; Ena L; Rogers JR; Lee J; Ostropolets A; Ryan PB; Liu H; Lee SM; Elkind MSV; Weng C
    J Am Med Inform Assoc; 2021 Jan; 28(1):14-22. PubMed ID: 33260201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world Clinical Outcomes Among Patients With Type 2 Diabetes Receiving Canagliflozin at a Specialty Diabetes Clinic: Subgroup Analysis by Baseline HbA
    Johnson JF; Parsa R; Bailey RA
    Clin Ther; 2017 Jun; 39(6):1123-1131. PubMed ID: 28495028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.
    Monte SV; Schentag JJ; Adelman MH; Paladino JA
    J Diabetes Sci Technol; 2010 Mar; 4(2):382-90. PubMed ID: 20307400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual aggregate analysis of eligibility features of clinical trials.
    He Z; Carini S; Sim I; Weng C
    J Biomed Inform; 2015 Apr; 54():241-55. PubMed ID: 25615940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes INSIDE: Improving Population HbA
    Furman RE; Harlan TS; LeBlanc L; Furman EC; Liptak G; Fonseca VA
    Diabetes Care; 2020 Feb; 43(2):329-336. PubMed ID: 31796573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.
    Wysham CH; Lefebvre P; Pilon D; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Duh MS; Ingham M
    J Diabetes Complications; 2019 Feb; 33(2):140-147. PubMed ID: 30554838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between different hemoglobin A1c levels and clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus.
    Davis KL; Wei W; Meyers JL; Kilpatrick BS; Pandya N
    J Am Med Dir Assoc; 2014 Oct; 15(10):757-62. PubMed ID: 25106810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i).
    Brunton S; Rozjabek HM; Pilon D; Lafeuille MH; Kamstra R; Wynant W; Bookhart BK; Lefebvre P
    Curr Med Res Opin; 2019 Sep; 35(9):1607-1614. PubMed ID: 30964362
    [No Abstract]   [Full Text] [Related]  

  • 40. Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population.
    Forlenza GP; Pyle LL; Maahs DM; Dunn TC
    Pediatr Diabetes; 2017 Nov; 18(7):622-628. PubMed ID: 27878929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.